Ebenbuild

The company develops digital twin technology for the human lung by combining physics-based modeling with patient-specific data. Its platform provides clinical decision support for optimizing ventilator settings in intensive care units and assists pharmaceutical companies with in silico trials for respiratory drug delivery. These virtual replicas allow for the simulation of ventilation strategies and the prediction of inhaled drug distribution.